DUB-le Trouble for Cell Survival

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Transmembrane Receptor DCC Associates with Protein Synthesis Machinery and Regulates Translation Joseph Tcherkezian, Perry A. Brittis, Franziska Thomas,
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
The BCL-2 Family Reunion Jerry E. Chipuk, Tudor Moldoveanu, Fabien Llambi, Melissa J. Parsons, Douglas R. Green Molecular Cell Volume 37, Issue 3, Pages.
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung Zvi Granot, Erik Henke, Elizabeth A. Comen, Tari A. King, Larry Norton, Robert Benezra.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Restoring cancer's death sentence
The Kinase-Independent, Second Life of CDK6 in Transcription
“Atypical” Regulation of Hedgehog-Dependent Cancers
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
Taking the Stress out of Melanoma
Volume 1, Issue 1, Pages (June 2007)
IRS-1: Auditing the effectiveness of mTOR inhibitors
Wild-Type RAS: Keeping Mutant RAS in CHK
Another Piece of the p27Kip1 Puzzle
HSF1 in Translation Cancer Cell
AMPK-Dependent Phosphorylation of ULK1 Induces Autophagy
A Mitochondrial Power Play in Lymphoma
Translational Homeostasis via eIF4E and 4E-BP1
A Sweet New Role for EGFR in Cancer
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
T.S. Karin Eisinger-Mathason, M. Celeste Simon  Cancer Cell 
The Wind God Promotes Lung Cancer
CALming Down T Cell Acute Leukemia
PICS-ure This: Prosenescence Therapy?
Muscle Fatigue from Losing Your PHD
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
David M. Lonard, Bert W. O'Malley  Molecular Cell 
David M. Lonard, Bert W. O'Malley  Molecular Cell 
P Bodies and the Control of mRNA Translation and Degradation
Breaking the Code of Polyadenylation-Induced Translation
Autophagy: A Sweet Process in Diabetes
Joseph W. Briggs, Jonathan D. Dinman  Molecular Cell 
IRS-1: Auditing the effectiveness of mTOR inhibitors
Joseph W. Briggs, Jonathan D. Dinman  Molecular Cell 
Volume 28, Issue 5, Pages (November 2015)
FAL1ing inside an Amplicon
Keeping Transcriptional Activators under Control
Autophagy Determines the Path on the TRAIL to Death
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches
Killing Lymphoma with Smac-Mimetics: As Easy as ABC?
Jonathan D. Licht, Jake Shortt, Ricky Johnstone  Cancer Cell 
LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis
Tumor Metabolism: MAGE-A Proteins Help TRIM Turn Over AMPK
Angelman Syndrome: Finding the Lost Arc
Ethylene Prunes Translation
Muscle Fatigue from Losing Your PHD
Life, Death, and Ubiquitin: Taming the Mule
Rfu1: Stimulus for the Ubiquitin Economy
Cell Migration: GSK3β Steers the Cytoskeleton's Tip
FAL1ing inside an Amplicon
Volume 10, Issue 3, Pages (September 2006)
Volume 54, Issue 5, Pages (June 2014)
All Roads Lead to the Ribosome
The TRIP from ULF to ARF Cancer Cell
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
The Tribble with APL: A New Road to Therapy
Volume 17, Issue 2, Pages (February 2010)
Gankyrin: An intriguing name for a novel regulator of p53 and RB
Volume 12, Issue 6, Pages (December 2007)
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
PTEN and p53: Who will get the upper hand?
Notching Up MYC Gives a LIC
Skp2, the FoxO1 hunter Cancer Cell
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Presentation transcript:

DUB-le Trouble for Cell Survival Joseph T. Opferman, Douglas R. Green  Cancer Cell  Volume 17, Issue 2, Pages 117-119 (February 2010) DOI: 10.1016/j.ccr.2010.01.011 Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 The Regulation of MCL-1 Protein Levels MCL-1 associates with a DUB, USP9X, which counters the effects of MULE and other E3 ubiquitin ligases and reduces proteasome-dependent degradation of the antiapoptotic protein. GSK3 phosphorylates MCL-1, promotes its dissociation from USP9X, and thereby increases ubiquitinylation and decreases its half-life. MCL-1 translation is regulated by mTOR, which can also be inhibited by GSK3, and thus inhibition of GSK3 elevates MCL-1 levels in two ways (via increased translation and half-life). Knockdown of USPX9 dramatically promotes loss of MCL-1, leading to the speculation that USPX9 may not only decrease half-life but also production of MCL-1. Cancer Cell 2010 17, 117-119DOI: (10.1016/j.ccr.2010.01.011) Copyright © 2010 Elsevier Inc. Terms and Conditions